FATE
Fate Therapeutics Inc
2.40$
+0.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +3.1% | -1.3% | -2.1% | -2.4% | +4.5% | -30.8% | -1.7% | -1.6% | -5.1% | -29.9% | +29.5% | – | |
| – | -6.2% | +15.9% | -12.3% | +22.2% | -22.5% | -19.1% | -3.1% | -32.1% | +13.7% | -28.9% | -10.5% | – | |
| – | – | – | -717.4% | – | -161.0% | – | – | +590.4% | +109.3% | -665.3% | – | – | |
| – | -68.0% | -52.5% | -40.7% | +870.6% | -80.2% | +1,120.4% | +13.9% | +61.7% | -45.9% | -79.9% | -66.5% | – | |
| – | +82.8% | -61.8% | -408.3% | – | -10.4% | +87.0% | -54.1% | +8.6% | +29.9% | -14.6% | -38.3% | – | |
| – | – | – | – | – | -200.0% | – | – | – | – | – | – | – | |
| – | – | – | -98.7% | -100.0% | – | -100.0% | – | +86.8% | -31.7% | – | – | – | |
| – | – | +830.8% | -206.2% | – | -286.8% | – | -141.4% | – | – | -220.5% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.